Trials / Completed
CompletedNCT00446979
Safety Study of UC-781 Vaginal Microbicide
Phase I Study of the Safety and Acceptability of UC-781 Topical Vaginal Microbicide in Women and Acceptability in Their Male Partners,Chiang Rai, Thailand
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- Centers for Disease Control and Prevention · Federal
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
This study will help determine whether UC-781 gel is safe when applied to the vagina twice daily for 14 days, and will assess whether women and men find the gel acceptable to use.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo gel | HEC (hydroxyethyl cellulose) Control Gel applied vaginally twice daily for two weeks |
| DRUG | UC 781 | UC 781 0.1% or UC 781 0.25%, applied vaginally twice daily for two intermenstrual weeks |
Timeline
- Start date
- 2007-06-01
- Completion
- 2007-10-01
- First posted
- 2007-03-13
- Last updated
- 2013-04-19
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT00446979. Inclusion in this directory is not an endorsement.